HK Stock MarketDetailed Quotes
03860 EPS HEALTH TECH
- 0.800
- 0.0000.00%
Trading Jul 25 09:00 CST
417.74MMarket Cap-19047P/E (TTM)
0.000High0.000Low0Volume0.000Open0.800Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)522.18MShares1.50052wk High6.40P/B417.74MFloat Cap0.70052wk Low--Dividend TTM522.18MShs Float2.680Historical High--Dividend LFY0.00%Amplitude0.380Historical Low--Avg Price5000Lot Size--Div YieldTTM--Div Yield LFY
EPS HEALTH TECH Key Stats
All
YOY
| (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | (Q6)Sep 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 50.06%-24.05M | 55.38%-8.18M | -111.75%-48.16M | ---18.34M | -418.72%-22.74M | ---- | -74.33%7.14M | ---- | -15.04%27.8M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -473.68%-1.09M | -2,351.61%-760K | -413.51%-190K | ---31K | 80.32%-37K | ---- | 3.59%-188K | ---- | 59.88%-195K | ---- |
| Impairment and provisions: | ---- | --1.97M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | --1.97M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---16.06M | ---- | ---- | ---- | --563K | ---- | ---- | ---- | ---- | ---- |
| -Other fair value changes | ---16.06M | ---- | ---- | ---- | --563K | ---- | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | 3,400.00%35K | -200.00%-1K | -66.67%1K | --1K | 101.67%3K | ---- | ---180K | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 3,400.00%35K | -200.00%-1K | -66.67%1K | --1K | 101.67%3K | ---- | ---180K | ---- | ---- | ---- |
| Depreciation and amortization: | 212.78%14.02M | 178.35%5.22M | 24.64%4.48M | --1.88M | 18.37%3.6M | ---- | 37.65%3.04M | ---- | 103.60%2.21M | ---- |
| -Depreciation | 72.22%2.59M | 536.38%3.69M | -39.50%1.5M | --580K | 153.94%2.48M | ---- | -55.73%977K | ---- | --2.21M | ---- |
| -Amortization of intangible assets | --7.98M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Financial expense | 22.00%7.07M | 1.22%3.15M | 25.60%5.8M | --3.11M | 3,292.65%4.61M | ---- | -7.48%136K | ---- | 32.43%147K | ---- |
| Operating profit before the change of operating capital | 47.27%-20.08M | 110.44%1.4M | -171.85%-38.07M | ---13.38M | -240.87%-14.01M | ---- | -66.81%9.94M | ---- | -10.39%29.96M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 209.97%8.61M | 64.49%-3.04M | 180.52%2.78M | ---8.57M | -151.75%-3.45M | ---- | -13.79%-1.37M | ---- | -248.46%-1.2M | ---- |
| Accounts receivable (increase)decrease | -633.31%-11.78M | -302.24%-26.05M | -112.30%-1.61M | ---6.48M | 435.45%13.06M | ---- | -2,880.71%-3.89M | ---- | 100.99%140K | ---- |
| Accounts payable increase (decrease) | -90.81%-3.34M | 179.42%33.88M | -124.40%-1.75M | --12.13M | 160.04%7.18M | ---- | -1,971.75%-11.95M | ---- | -120.42%-577K | ---- |
| prepayments (increase)decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 119.42%3.06M | ---- |
| Special items for working capital changes | ---- | 171.12%1.96M | ---- | ---2.75M | --1.52M | ---- | ---- | ---- | ---- | ---- |
| Cash from business operations | 27.19%-27.17M | 129.51%5.73M | -967.83%-37.31M | -119.41%-19.42M | 159.09%4.3M | 261.18%100.01M | -123.19%-7.28M | -1,516.68%-62.05M | 333.28%31.37M | 83.33%-3.84M |
| Other taxs | -75.22%-1.4M | 37.80%-497K | -188.45%-799K | 38.40%-799K | 94.58%-277K | 1.82%-1.3M | 24.06%-5.11M | -61.49%-1.32M | -104.47%-6.73M | 3.88%-818K |
| Net cash from operations | 25.04%-28.57M | 125.89%5.23M | -1,047.46%-38.11M | -120.48%-20.22M | 132.48%4.02M | 255.77%98.71M | -150.23%-12.38M | -1,261.02%-63.37M | 523.71%24.65M | 80.50%-4.66M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 473.68%1.09M | 2,351.61%760K | 413.51%190K | 138.46%31K | -80.32%37K | -92.17%13K | 13.25%188K | 144.12%166K | -53.50%166K | -76.06%68K |
| Decrease in deposits (increase) | ---- | ---- | -210.61%-9M | ---5M | 10,667.53%8.14M | ---- | -101.12%-77K | -100.87%-60K | 631.10%6.87M | 389.75%6.93M |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | --180K | ---- | ---- | ---- |
| Purchase of fixed assets | -109.09%-5.04M | -2,389.47%-1.89M | -751.24%-2.41M | -280.95%-76K | 46.10%-283K | 109.57%42K | -53.06%-525K | -222.79%-439K | 88.34%-343K | 84.75%-136K |
| Acquisition of subsidiaries | ---16.46M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | 95.37%-164K | ---131K | ---3.54M | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | --2.05M | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -79.24%-20.4M | 78.13%-1.13M | -361.62%-11.38M | -346.12%-5.18M | 1,959.40%4.35M | 731.53%2.1M | -103.50%-234K | -104.86%-333K | 506.57%6.69M | 750.74%6.86M |
| Net cash before financing | 1.05%-48.97M | 116.15%4.1M | -691.07%-49.49M | -125.19%-25.39M | 166.37%8.37M | 258.26%100.82M | -140.26%-12.62M | -2,994.23%-63.7M | 1,258.34%31.34M | 109.54%2.2M |
| Cash flow from financing activities | ||||||||||
| New borrowing | --64.42M | 7,081.70%16.09M | ---- | --224K | 954.09%115.48M | ---- | -28.10%10.96M | ---- | -5.78%15.24M | -3.86%12.82M |
| Refund | -2.85%-22.95M | 40.66%-14.54M | -1,267.16%-22.31M | -4,723.82%-24.51M | 84.38%-1.63M | ---508K | 31.44%-10.45M | ---- | 5.78%-15.24M | -84.37%-12.82M |
| Interest paid - financing | -88.22%-4.44M | -32.51%-1.72M | -157.08%-2.36M | -401.94%-1.3M | -575.00%-918K | -279.41%-258K | 7.48%-136K | 18.07%-68K | -32.43%-147K | -38.33%-83K |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -6.67%-8M | -6.67%-8M |
| Absorb investment income | ---- | ---- | ---- | ---- | --2.06M | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | ---- | 53.73%-2.38M | ---- | ---5.14M | ---- | ---- | -75.85%-2.18M | ---793K | ---1.24M | ---- |
| Net cash from financing operations | 221.27%33.66M | 91.70%-2.55M | -124.68%-27.76M | -1,464.70%-30.72M | 6,306.24%112.46M | -127.99%-1.96M | 80.70%-1.81M | 90.08%-861K | -21.41%-9.39M | -600.81%-8.68M |
| Effect of rate | -208.17%-622K | -372.11%-517K | -72.30%575K | 804.76%190K | 1,197.50%2.08M | 113.82%21K | 220.30%160K | -13.43%-152K | 43.64%-133K | 4.29%-134K |
| Other items affecting net cash | ---- | ---- | ---- | --14.33M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net Cash | 80.18%-15.31M | 103.72%1.55M | -163.93%-77.25M | -142.26%-41.77M | 937.47%120.83M | 253.11%98.85M | -165.74%-14.43M | -897.11%-64.56M | 504.50%21.95M | 73.37%-6.48M |
| Begining period cash | -36.84%131.47M | -36.84%131.47M | 144.20%208.14M | 144.20%208.14M | -14.34%85.24M | -14.34%85.24M | 28.08%99.5M | 28.08%99.5M | -6.79%77.69M | -6.79%77.69M |
| Cash at the end | -12.12%115.54M | -20.44%132.51M | -36.84%131.47M | -9.53%166.56M | 144.20%208.14M | 429.23%184.11M | -14.34%85.24M | -51.06%34.79M | 28.08%99.5M | 20.68%71.08M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --71.08M |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --71.08M |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | KPMG | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg